Literature DB >> 22269557

Reliability of simulator driving tool for evaluation of sleepiness, fatigue and driving performance.

D Davenne1, R Lericollais, P Sagaspe, J Taillard, A Gauthier, S Espié, P Philip.   

Abstract

STUDY
OBJECTIVE: To compare the impact of extended wakefulness (i.e., sleepiness) and prolonged driving (i.e., fatigue) at the wheel in simulated versus real-life driving conditions.
DESIGN: Participants drove on an INRETS-MSIS SIM2 simulator in a research laboratory or an open French highway during 3 nocturnal driving sessions. A dose-response design of duration of nocturnal driving was used: a 2 h short driving session (3-5 AM), a 4 h intermediate driving session (1-5 AM) and an 8 h long driving session (9 PM-5 AM). PARTICIPANTS: Two groups of healthy male drivers (20 for simulated driving and 14 drivers for real driving; mean age±SD=22.3±1.6 years), free of sleep disorders. MEASUREMENTS: Number of inappropriate line crossings, self-rated fatigue and sleepiness were recorded in the last hour of driving sessions to control the effects of prior waking time and time of day.
RESULTS: Compared to the daytime reference session, both simulated and real driving performance were affected by a short nocturnal driving session (P<.05 and P<.001, respectively). Extension of nocturnal driving duration affected simulated performance nonlinearly and more severely than that of real driving (P<.001). Compared to the daytime reference session, short nocturnal simulated and real driving sessions increased self-perceived fatigue and sleepiness. Real and simulated driving conditions had an identical impact on fatigue and sleepiness during extended periods of nocturnal driving.
CONCLUSIONS: In healthy subjects, the INRETS-MSIS SIM2 simulator appropriately measures driving impairment in terms of inappropriate line crossings related to extended wakefulness but has limitations to measure the impact of extended driving on drivers' performance.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22269557     DOI: 10.1016/j.aap.2011.09.046

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  7 in total

1.  The relationship between driving simulation performance and obstructive sleep apnoea risk, daytime sleepiness, obesity and road traffic accident history of commercial drivers in Turkey.

Authors:  Ezgi Demirdöğen Çetinoğlu; Aslı Görek Dilektaşlı; Nefise Ateş Demir; Güven Özkaya; Nilüfer Aylin Acet; Eda Durmuş; Ahmet Ursavaş; Mehmet Karadağ; Ercüment Ege
Journal:  Sleep Breath       Date:  2015-01-22       Impact factor: 2.816

Review 2.  Commonly Used Assessment Method to Evaluate Mental Workload for Multiple Driving Distractions: A Systematic Review.

Authors:  Nurainaa Kabilmiharbi; Nor Kamaliana Khamis; Nor Azila Noh
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

3.  Individual variability and predictors of driving simulator impairment in patients with obstructive sleep apnea.

Authors:  Andrew Vakulin; Peter G Catcheside; Stuart D Baulk; Nick A Antic; Siobhan Banks; Jillian Dorrian; R Doug McEvoy
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

4.  Circadian Characteristics of Older Adults and Aerobic Capacity.

Authors:  Sandrine Dupont Rocher; Nicolas Bessot; Bruno Sesboüé; Jan Bulla; Damien Davenne
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-23       Impact factor: 6.053

5.  Exploring background risk factors for fatigue crashes involving truck drivers on regional roadway networks: a case control study in Jiangxi and Shaanxi, China.

Authors:  Changkun Chen; Jun Zhang
Journal:  Springerplus       Date:  2016-05-10

6.  Driver fatigue detection through multiple entropy fusion analysis in an EEG-based system.

Authors:  Jianliang Min; Ping Wang; Jianfeng Hu
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

7.  Morning anaerobic performance is not altered by vigilance impairment.

Authors:  Romain Lericollais; Antoine Gauthier; Nicolas Bessot; Amira Zouabi; Damien Davenne
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.